Urinary Incontinence Devices Market By Product (Urinary Catheters, Urethral Slings, Electrical Stimulation Devices, Artificial Urinary Sphincters, Others), By Type (External Devices, Internal Devices), By Patient Type (Male, Female), By End-User (Hospitals And Clinics, Ambulatory Surgery Centers, Others), By Geography is expected to grow at a steady CAGR forecast till 2027 owing to the development of innovative devices and and surge in urological conditions.
Global Urinary Incontinence Devices Market was valued at USD 2.97 billion in 2021, growing at a CAGR of 6.36% during the forecast period from 2022 to 2027, to reach USD 4.30 billion by 2027. The Urinary Incontinence Devices market is expected to witness growth due to the rising prevalence of urinary incontinence cases, development of innovative devices, aging population prone to urological conditions like urinary tract infections, weakening of pelvic floor, and conditions including pregnancy, diabetes, menopause, and Parkinson's disease.
Urinary Incontinence Devices Market has significantly increased due to the rising prevalence of urinary incontinence cases. As per the National Association for Continence 2018, over 33 million Americans suffer from some type of urinary incontinence or bladder condition. Owing to the growing burden of urinary incontinence across the globe, the Urinary Incontinence Devices market has been rising significantly.
In addition, the development of urinary incontinence advanced devices is thriving at a great pace. For instance, in February 2020, Atlantic Therapeutics announced that the US FDA granted over-the-counter (OTC) clearance to INNOVO®, a non-invasive device for non-invasive device for stress urinary incontinence (SUI), clinically proven, and wearable device that treats the root cause of bladder weakness. INNOVO® was previously available in the US by prescription, with more than 3.5 million safe and successful therapy sessions delivered worldwide. Such technological advancement in the field of Urinary Incontinence Devices is likely to boost the Global Urinary Incontinence Devices Market.
Also, the aging population is more prone to urinary incontinence, by the time urological conditions like urinary tract infections and weakening of pelvic floor develop. According to the Urology Centers of Alabama 2018, although overactive bladders (OAB) can happen to anyone, the most common ages are post-40 for men and, especially, women. According to the CentraState Healthcare System, 2019, over the age of 40, one in three women experience symptoms of urinary incontinence, while it affects one in two women over age 60 globally. For women age 80 and older, it's rare not to have some type of incontinence. Therefore, as the aging population increases, there will be more prevalence of urological conditions, which will eventually boost the growth of the Urinary Incontinence market.
The outbreak of the COVID-19 pandemic had a profound impact across the globe. The pandemic led to the cancellation of outpatient visits and the suspension of non-emergency hospitals and procedures. This resulted in the reduced number of routine clinical examinations of the urological visits and related procedures. Thus, the number of patients waiting to get urinary incontinence devices through surgery increased over time. Therefore, the demand for Urinary Incontinence Devices has accelerated over the forecast period which will drive the market growth.
However, certain factors like less awareness among the patient population regarding incontinence and post-operative complications are expected to restrict the growth of the Global Urinary Incontinence Devices Market.
Urinary Incontinence Devices Market by Product (Urinary Catheters, Urethral Slings, Electrical Stimulation Devices, Artificial Urinary Sphincters, Others), by Type (External Devices, Internal Devices), by Patient Type (Male, Female), by End-User (Hospitals and Clinics, Ambulatory Surgery Centers, Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World).
Urinary Incontinence Devices market product segment, the Urethral Slings market segment will hold the major share of the Global Urinary Incontinence Devices market. The large market share of this product segment can be attributed to the growing patient adoption for these devices due to quick relief. Moreover, Urethral Slings are more advanced devices and have replaced all the conventional devices available in the market.
Furthermore, these slings are made up of different materials like ligament, tissue, tendons taken from the patient or they can also be manufactured from synthetic sources like plastic.
The rising prevalence of urinary incontinence among the women population is also increasing the demand for urethral sling surgery. Moreover, the significant research activities taking place in the Urinary Incontinence arena will eventually boost the market.
Additionally, a shift in trend from conventional devices to advanced devices can be seen among the patient population. This will increase the acceptance of Urinary Incontinence Devices for patients. Hence, all the above-mentioned factors are expected to drive the segment growth of the Urinary Incontinence Devices market.
North America is expected to dominate the overall Urinary Incontinence Devices market during the forecast period. This domination is due to the rising prevalence of urinary incontinence cases and urological conditions among men and women in the region. As per Urology Care Foundation 2021, a quarter to a third of men and women in the US suffer from urinary incontinence. About 33 million have overactive bladder representing symptoms of urgency, frequency, and urge incontinence.
According to the same statistics, as many as 30% of men and 40% of women in the United States live with OAB symptoms. Thus, the burgeoning cases of the diseases will contribute to the growth of the Urinary Incontinence Devices Market in the region as the demand will increase.
Further, in North America and at the global level the United States represents the largest market worldwide supported by the development of advanced devices and easy regulatory initiatives by the government. One such technological advancement is the development of implantable tibial neuromodulation (TNM) device designed to provide relief from symptoms of bladder incontinence, developed by Medtronic PLC. The device received approval from US FDA to proceed with an investigational device exemption (IDE) trial in April 2021.
Europe and Asia-Pacific region have the future potential growth for the Global Urinary Incontinence Devices market. This is owing to the rising burden of urological diseases and COVID-19 pandemic in the European region countries and Asian countries. Rising product launch and commercialization agreements among the key manufacturers and other companies are anticipated to boost the Urinary Incontinence Devices market. For instance, in April 2021, in Australia, Analytica Ltd. signed a joint venture agreement with Hebei Nacol Bio-Technology Co. Ltd. and Shijiazhuang Biosphere Pty Ltd., of Hebei Province, China, to manufacture and distribute its Pericoach device for urinary incontinence in China, Macau, Hong Kong, and Taiwan. Such initiatives are anticipated to boost the Urinary Incontinence Devices Market.
Some of the key market players operating in the Global Urinary Incontinence Devices Market include NeoTract, Inc., Cook Medical Inc., C.R. Bard Inc., Coloplast Corporation, Boston Scientific Corporation, Ethicon US, LLC, Medtronic PLC, A.M.I. Ltd., Teleflex Incorporated, Hollister Incorporated, ConvaTec Group PLC, Caldera Medical Inc., Prosurg, Inc., Laborie, Inc., Becton, Dickinson and Company, ZSI Surgical Implants, Atlantic Therapeutics, B. Braun Melsungen AG, Flexicare (Group) Limited, InControl Medical among others.
1. What are Urinary Incontinence Devices?
Urinary Incontinence Devices are medical devices that help in collecting and holding urine. Urinary Incontinence (UI) is a medical disorder in which a person unconsciously urinates. It is differentiated into four types namely, stress urinary incontinence, urge urinary incontinence, overflow urinary incontinence, and functional urinary incontinence.
2. What is the market for Global Urinary Incontinence Devices?
Global Urinary Incontinence Devices Market was valued at USD 2.97 billion in 2021, growing at a CAGR of 6.36% during the forecast period from 2022 to 2027, to reach USD 4.30 billion by 2027.
3. What are the drivers for Global Urinary Incontinence Devices?
The major drivers driving the demand for Urinary Incontinence Devices are the rising prevalence of urinary incontinence cases, the development of innovative devices, the aging population prone to urological conditions like urinary tract infections, weakening of pelvic floor, and conditions including pregnancy, diabetes, menopause, and Parkinson's disease.
4. Who are the key players operating in Global Urinary Incontinence Devices?
Some of the key market players operating in the Urinary Incontinence Devices market include NeoTract, Inc., Cook Medical Inc., C.R. Bard Inc., Coloplast Corporation, Boston Scientific Corporation, Ethicon US, LLC, Medtronic PLC, A.M.I. Ltd., Teleflex Incorporated, Hollister Incorporated, ConvaTec Group PLC, Caldera Medical Inc., Prosurg, Inc., Laborie, Inc., Becton, Dickinson and Company, ZSI Surgical Implants, Atlantic Therapeutics, B. Braun Melsungen AG, Flexicare (Group) Limited, InControl Medical, and others.
5. Which region has the highest share in the Urinary Incontinence Devices market?
North America is expected to dominate the overall global Urinary Incontinence Devices market during the forecast period from 2022 to 2027. This domination is due to the rising prevalence of urinary incontinence cases and urological conditions among men and women in the region.
Global Urinary Incontinence Devices Market was valued at USD 2.97 billion in 2021, growing at a CAGR of 6.36% during the forecast period from 2022 to 2027, to reach USD 4.30 billion by 2027. The Urinary Incontinence Devices market is expected to witness growth due to the rising prevalence of urinary incontinence cases, development of innovative devices, aging population prone to urological conditions like urinary tract infections, weakening of pelvic floor, and conditions including pregnancy, diabetes, menopause, and Parkinson's disease.
Urinary Incontinence Devices Market Dynamics:
Urinary Incontinence Devices Market has significantly increased due to the rising prevalence of urinary incontinence cases. As per the National Association for Continence 2018, over 33 million Americans suffer from some type of urinary incontinence or bladder condition. Owing to the growing burden of urinary incontinence across the globe, the Urinary Incontinence Devices market has been rising significantly.
In addition, the development of urinary incontinence advanced devices is thriving at a great pace. For instance, in February 2020, Atlantic Therapeutics announced that the US FDA granted over-the-counter (OTC) clearance to INNOVO®, a non-invasive device for non-invasive device for stress urinary incontinence (SUI), clinically proven, and wearable device that treats the root cause of bladder weakness. INNOVO® was previously available in the US by prescription, with more than 3.5 million safe and successful therapy sessions delivered worldwide. Such technological advancement in the field of Urinary Incontinence Devices is likely to boost the Global Urinary Incontinence Devices Market.
Also, the aging population is more prone to urinary incontinence, by the time urological conditions like urinary tract infections and weakening of pelvic floor develop. According to the Urology Centers of Alabama 2018, although overactive bladders (OAB) can happen to anyone, the most common ages are post-40 for men and, especially, women. According to the CentraState Healthcare System, 2019, over the age of 40, one in three women experience symptoms of urinary incontinence, while it affects one in two women over age 60 globally. For women age 80 and older, it's rare not to have some type of incontinence. Therefore, as the aging population increases, there will be more prevalence of urological conditions, which will eventually boost the growth of the Urinary Incontinence market.
The outbreak of the COVID-19 pandemic had a profound impact across the globe. The pandemic led to the cancellation of outpatient visits and the suspension of non-emergency hospitals and procedures. This resulted in the reduced number of routine clinical examinations of the urological visits and related procedures. Thus, the number of patients waiting to get urinary incontinence devices through surgery increased over time. Therefore, the demand for Urinary Incontinence Devices has accelerated over the forecast period which will drive the market growth.
However, certain factors like less awareness among the patient population regarding incontinence and post-operative complications are expected to restrict the growth of the Global Urinary Incontinence Devices Market.
Urinary Incontinence Devices Market Segment Analysis:
Urinary Incontinence Devices Market by Product (Urinary Catheters, Urethral Slings, Electrical Stimulation Devices, Artificial Urinary Sphincters, Others), by Type (External Devices, Internal Devices), by Patient Type (Male, Female), by End-User (Hospitals and Clinics, Ambulatory Surgery Centers, Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World).
Urinary Incontinence Devices market product segment, the Urethral Slings market segment will hold the major share of the Global Urinary Incontinence Devices market. The large market share of this product segment can be attributed to the growing patient adoption for these devices due to quick relief. Moreover, Urethral Slings are more advanced devices and have replaced all the conventional devices available in the market.
Furthermore, these slings are made up of different materials like ligament, tissue, tendons taken from the patient or they can also be manufactured from synthetic sources like plastic.
The rising prevalence of urinary incontinence among the women population is also increasing the demand for urethral sling surgery. Moreover, the significant research activities taking place in the Urinary Incontinence arena will eventually boost the market.
Additionally, a shift in trend from conventional devices to advanced devices can be seen among the patient population. This will increase the acceptance of Urinary Incontinence Devices for patients. Hence, all the above-mentioned factors are expected to drive the segment growth of the Urinary Incontinence Devices market.
North America Is Expected To Dominate The Overall Global Urinary Incontinence Devices Market:
North America is expected to dominate the overall Urinary Incontinence Devices market during the forecast period. This domination is due to the rising prevalence of urinary incontinence cases and urological conditions among men and women in the region. As per Urology Care Foundation 2021, a quarter to a third of men and women in the US suffer from urinary incontinence. About 33 million have overactive bladder representing symptoms of urgency, frequency, and urge incontinence.
According to the same statistics, as many as 30% of men and 40% of women in the United States live with OAB symptoms. Thus, the burgeoning cases of the diseases will contribute to the growth of the Urinary Incontinence Devices Market in the region as the demand will increase.
Further, in North America and at the global level the United States represents the largest market worldwide supported by the development of advanced devices and easy regulatory initiatives by the government. One such technological advancement is the development of implantable tibial neuromodulation (TNM) device designed to provide relief from symptoms of bladder incontinence, developed by Medtronic PLC. The device received approval from US FDA to proceed with an investigational device exemption (IDE) trial in April 2021.
Europe and Asia-Pacific region have the future potential growth for the Global Urinary Incontinence Devices market. This is owing to the rising burden of urological diseases and COVID-19 pandemic in the European region countries and Asian countries. Rising product launch and commercialization agreements among the key manufacturers and other companies are anticipated to boost the Urinary Incontinence Devices market. For instance, in April 2021, in Australia, Analytica Ltd. signed a joint venture agreement with Hebei Nacol Bio-Technology Co. Ltd. and Shijiazhuang Biosphere Pty Ltd., of Hebei Province, China, to manufacture and distribute its Pericoach device for urinary incontinence in China, Macau, Hong Kong, and Taiwan. Such initiatives are anticipated to boost the Urinary Incontinence Devices Market.
Urinary Incontinence Devices Market Key Players:
Some of the key market players operating in the Global Urinary Incontinence Devices Market include NeoTract, Inc., Cook Medical Inc., C.R. Bard Inc., Coloplast Corporation, Boston Scientific Corporation, Ethicon US, LLC, Medtronic PLC, A.M.I. Ltd., Teleflex Incorporated, Hollister Incorporated, ConvaTec Group PLC, Caldera Medical Inc., Prosurg, Inc., Laborie, Inc., Becton, Dickinson and Company, ZSI Surgical Implants, Atlantic Therapeutics, B. Braun Melsungen AG, Flexicare (Group) Limited, InControl Medical among others.
Recent Developmental Activities in the Urinary Incontinence Devices Market:
- In September 2021, at American Urological Association Annual Meeting, a novel, ultra-miniaturized sacral nerve modulation (SNM) system was shown to be both efficacious and safe in treating patients with urge urinary incontinence (UUI), according to findings from the feasibility phase of the SANS-UUI study.
- In May 2021, the University of Washington School of Medicine developed and tested 3 new devices to relieve symptoms of urinary incontinence. The first device tested in a clinical trial was a neuromodulation device. The second device involves an electrode about the size of a small pill and is implanted through a needle in the lower back alongside one of the main pelvic nerves. The third device is a soft, rubber ring with embedded electrodes placed in the vagina like a pessary or diaphragm.
Key Takeaways from the Urinary Incontinence Devices Market Report Study
- Market size analysis for current market size (2021), and market forecast for 5 years (2022-2027)
- The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Urinary Incontinence Devices market.
- Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
- Key companies dominating the Global Urinary Incontinence Devices Market.
- Various opportunities are available for the other competitor in the Urinary Incontinence Devices Market space.
- What are the top-performing segments in 2021? How these segments will perform in 2027?
- Which are the top-performing regions and countries in the current market scenario?
- Which are the regions and countries where companies should have concentrated on opportunities for Urinary Incontinence Devices market growth in the coming future?
Target Audience who can be benefited from this Urinary Incontinence Devices Market Report Study
- Urinary Incontinence Devices providers
- Research organizations and consulting companies
- Urinary Incontinence Devices related organization, association, forum, and other alliances
- Government and corporate offices
- Start-up companies, venture capitalists, and private equity firms
- Distributors and Traders in Urinary Incontinence Devices
- Various End-users want to know more about the Urinary Incontinence Devices Market and the latest technological developments in the Urinary Incontinence Devices market.
Frequently Asked Questions for Urinary Incontinence Devices Market:
1. What are Urinary Incontinence Devices?
Urinary Incontinence Devices are medical devices that help in collecting and holding urine. Urinary Incontinence (UI) is a medical disorder in which a person unconsciously urinates. It is differentiated into four types namely, stress urinary incontinence, urge urinary incontinence, overflow urinary incontinence, and functional urinary incontinence.
2. What is the market for Global Urinary Incontinence Devices?
Global Urinary Incontinence Devices Market was valued at USD 2.97 billion in 2021, growing at a CAGR of 6.36% during the forecast period from 2022 to 2027, to reach USD 4.30 billion by 2027.
3. What are the drivers for Global Urinary Incontinence Devices?
The major drivers driving the demand for Urinary Incontinence Devices are the rising prevalence of urinary incontinence cases, the development of innovative devices, the aging population prone to urological conditions like urinary tract infections, weakening of pelvic floor, and conditions including pregnancy, diabetes, menopause, and Parkinson's disease.
4. Who are the key players operating in Global Urinary Incontinence Devices?
Some of the key market players operating in the Urinary Incontinence Devices market include NeoTract, Inc., Cook Medical Inc., C.R. Bard Inc., Coloplast Corporation, Boston Scientific Corporation, Ethicon US, LLC, Medtronic PLC, A.M.I. Ltd., Teleflex Incorporated, Hollister Incorporated, ConvaTec Group PLC, Caldera Medical Inc., Prosurg, Inc., Laborie, Inc., Becton, Dickinson and Company, ZSI Surgical Implants, Atlantic Therapeutics, B. Braun Melsungen AG, Flexicare (Group) Limited, InControl Medical, and others.
5. Which region has the highest share in the Urinary Incontinence Devices market?
North America is expected to dominate the overall global Urinary Incontinence Devices market during the forecast period from 2022 to 2027. This domination is due to the rising prevalence of urinary incontinence cases and urological conditions among men and women in the region.
Table of Contents
1. Urinary Incontinence Devices Market Report Introduction2. Urinary Incontinence Devices Market Executive summary
2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment
2.4. Financial Benchmarking
3. Regulatory and Patent Analysis
3.1. The United States
3.2. Europe
3.2.1. Germany
3.2.2. France
3.2.3. Italy
3.2.4. Spain
3.2.5. The U.K.
3.3. Japan
4. Urinary Incontinence Devices Market Key factors analysis
4.1. Urinary Incontinence Devices Market Drivers
4.1.1. Rising prevalence of urinary incontinence cases
4.1.2. The conditions including pregnancy, diabetes, menopause, and Parkinson's diseases
4.1.3. The surge in the aging population prone to urological conditions
4.1.4. Development of innovative devices
4.2. Urinary Incontinence Devices Restraints and Challenges
4.2.1. Less awareness among the patient population regarding incontinence
4.2.2. Post-operative complications
4.3. Urinary Incontinence Devices Opportunities
4.3.1. Growing preference for devices that can be used in home settings
4.3.2. Growth opportunities in emerging countries
5. Urinary Incontinence Devices Porter's Five Forces Analysis
5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry
6. COVID-19 Impact Analysis on Urinary Incontinence Devices Market
7. Urinary Incontinence Devices Market layout
7.1. By Product
7.1.1. Urinary Catheters
7.1.2. Urethral Slings
7.1.3. Electrical Stimulation Devices
7.1.4. Artificial Urinary Sphincters
7.1.5. Others
7.2. By Type
7.2.1. External Devices
7.2.2. Internal Devices
7.3. By Patient Type
7.3.1. Male
7.3.2. Female
7.4. By End User
7.4.1. Hospitals and Clinics
7.4.2. Ambulatory Surgical Centers (ASCs)
7.4.3. Others
7.5. By Geography
7.5.1. North America
7.5.1.1. North America Urinary Incontinence Devices Market, by Product
7.5.1.2. North America Urinary Incontinence Devices Market, by Type
7.5.1.3. North America Urinary Incontinence Devices Market, by Patient Type
7.5.1.4. North America Urinary Incontinence Devices Market, by End User
7.5.1.5. North America Urinary Incontinence Devices Market, by Country
7.5.1.5.1. United States
7.5.1.5.2. Canada
7.5.1.5.3. Mexico
7.5.2. Europe
7.5.2.1. Europe Urinary Incontinence Devices Market, by Product
7.5.2.2. Europe Urinary Incontinence Devices Market, by Type
7.5.2.3. Europe Urinary Incontinence Devices Market, by Patient Type
7.5.2.4. Europe Urinary Incontinence Devices Market, by End User
7.5.2.5. Europe Urinary Incontinence Devices Market, by Country
7.5.2.5.1. France
7.5.2.5.2. Germany
7.5.2.5.3. United Kingdom
7.5.2.5.4. Italy
7.5.2.5.5. Spain
7.5.2.5.6. Russia
7.5.2.5.7. Rest of Europe
7.5.3. Asia-Pacific
7.5.3.1. Asia-Pacific Urinary Incontinence Devices Market, by Product
7.5.3.2. Asia-Pacific Urinary Incontinence Devices Market, by Type
7.5.3.3. Asia-Pacific Urinary Incontinence Devices Market, by Patient Type
7.5.3.4. Asia-Pacific Urinary Incontinence Devices Market, by End User
7.5.3.5. Asia-Pacific Urinary Incontinence Devices Market, by Country
7.5.3.5.1. China
7.5.3.5.2. Japan
7.5.3.5.3. India
7.5.3.5.4. Australia
7.5.3.5.5. South Korea
7.5.3.5.6. Rest of Asia Pacific
7.5.4. Rest of the World (RoW)
7.5.4.1. RoW Urinary Incontinence Devices Market, by Product
7.5.4.2. RoW Urinary Incontinence Devices Market, by Type
7.5.4.3. RoW Urinary Incontinence Devices Market, by Patient Type
7.5.4.4. RoW Urinary Incontinence Devices Market, by End User
7.5.4.5. RoW Urinary Incontinence Devices Market, by Region
7.5.4.5.1. Middle East
7.5.4.5.2. Africa
7.5.4.5.3. South America
8. Urinary Incontinence Devices Global Company Share Analysis - Key 3-5 Companies
9. Urinary Incontinence Devices Company and Product Profiles
9.1. NeoTract, Inc.
9.1.1. Company Overview
9.1.2. Company Snapshot
9.1.3. Financial Overview
9.1.4. Product Listing
9.1.5. Entropy
9.2. Cook Medical Inc.
9.2.1. Company Overview
9.2.2. Company Snapshot
9.2.3. Financial Overview
9.2.4. Product Listing
9.2.5. Entropy
9.3. C.R. Bard Inc.
9.3.1. Company Overview
9.3.2. Company Snapshot
9.3.3. Financial Overview
9.3.4. Product Listing
9.3.5. Entropy
9.4. Coloplast Corporation
9.4.1. Company Overview
9.4.2. Company Snapshot
9.4.3. Financial Overview
9.4.4. Product Listing
9.4.5. Entropy
9.5. Boston Scientific Corporation
9.5.1. Company Overview
9.5.2. Company Snapshot
9.5.3. Financial Overview
9.5.4. Product Listing
9.5.5. Entropy
9.6. Ethicon US, LLC
9.6.1. Company Overview
9.6.2. Company Snapshot
9.6.3. Financial Overview
9.6.4. Product Listing
9.6.5. Entropy
9.7. Medtronic PLC
9.7.1. Company Overview
9.7.2. Company Snapshot
9.7.3. Financial Overview
9.7.4. Product Listing
9.7.5. Entropy
9.8. A.M.I. Ltd.
9.8.1. Company Overview
9.8.2. Company Snapshot
9.8.3. Financial Overview
9.8.4. Product Listing
9.8.5. Entropy
9.9. Teleflex Incorporated
9.9.1. Company Overview
9.9.2. Company Snapshot
9.9.3. Financial Overview
9.9.4. Product Listing
9.9.5. Entropy
9.10. Hollister Incorporated
9.10.1. Company Overview
9.10.2. Company Snapshot
9.10.3. Financial Overview
9.10.4. Product Listing
9.10.5. Entropy
9.11. ConvaTec Group PLC
9.11.1. Company Overview
9.11.2. Company Snapshot
9.11.3. Financial Overview
9.11.4. Product Listing
9.11.5. Entropy
9.12. Caldera Medical Inc.
9.12.1. Company Overview
9.12.2. Company Snapshot
9.12.3. Financial Overview
9.12.4. Product Listing
9.12.5. Entropy
9.13. Prosurg, Inc.
9.13.1. Company Overview
9.13.2. Company Snapshot
9.13.3. Financial Overview
9.13.4. Product Listing
9.13.5. Entropy
9.14. Laborie, Inc.
9.14.1. Company Overview
9.14.2. Company Snapshot
9.14.3. Financial Overview
9.14.4. Product Listing
9.14.5. Entropy
9.15. Becton, Dickinson and Company
9.15.1. Company Overview
9.15.2. Company Snapshot
9.15.3. Financial Overview
9.15.4. Product Listing
9.15.5. Entropy
9.16. ZSI Surgical Implants
9.16.1. Company Overview
9.16.2. Company Snapshot
9.16.3. Financial Overview
9.16.4. Product Listing
9.16.5. Entropy
9.17. Atlantic Therapeutics
9.17.1. Company Overview
9.17.2. Company Snapshot
9.17.3. Financial Overview
9.17.4. Product Listing
9.17.5. Entropy
9.18. B. Braun Melsungen AG
9.18.1. Company Overview
9.18.2. Company Snapshot
9.18.3. Financial Overview
9.18.4. Product Listing
9.18.5. Entropy
9.19. Flexicare (Group) Limited
9.19.1. Company Overview
9.19.2. Company Snapshot
9.19.3. Financial Overview
9.19.4. Product Listing
9.19.5. Entropy
9.20. InControl Medical
9.20.1. Company Overview
9.20.2. Company Snapshot
9.20.3. Financial Overview
9.20.4. Product Listing
9.20.5. Entropy
10. Project Approach
10.1. Secondary Sources
10.2. Primary Sources
10.3. Data Triangulation
10.4. Key Expert Opinions
11. KOL Views
12. Publisher Capabilities
13. Disclaimer
14. About the PublisherList of Tables
Table 1: Competitive Analysis
Table 2: COVID-19 Impact Analysis on Urinary Incontinence Devices Market
Table 3: Urinary Incontinence Devices Market Analysis in Global (2019-2027)
Table 4: Urinary Incontinence Devices Market Analysis in Global by Product (2019-2027)
Table 5: Urinary Incontinence Devices Market Analysis in Global by Type (2019-2027)
Table 6: Urinary Incontinence Devices Market Analysis in Global by Patient Type (2019-2027)
Table 7: Urinary Incontinence Devices Market Analysis in Global by End User (2019-2027)
Table 8: Urinary Incontinence Devices Market Analysis in Global by Geography (2019-2027)
Table 9: Urinary Incontinence Devices Market Analysis in North America (2019-2027)
Table 10: Urinary Incontinence Devices Market Analysis in North America by Product (2019-2027)
Table 11: Urinary Incontinence Devices Market Analysis in North America by Type (2019-2027)
Table 12: Urinary Incontinence Devices Market Analysis in North America by Patient Type (2019-2027)
Table 13: Urinary Incontinence Devices Market Analysis in North America by End User (2019-2027)
Table 14: Urinary Incontinence Devices Market Analysis in North America by Country (2019-2027)
Table 15: Urinary Incontinence Devices Market Analysis in the US (2019-2027)
Table 16: Urinary Incontinence Devices Market Analysis in Canada (2019-2027)
Table 17: Urinary Incontinence Devices Market Analysis in Mexico (2019-2027)
Table 18: Urinary Incontinence Devices Market Analysis in Europe (2019-2027)
Table 19: Urinary Incontinence Devices Market Analysis in Europe by Product (2019-2027)
Table 20: Urinary Incontinence Devices Market Analysis in Europe by Type (2019-2027)
Table 21: Urinary Incontinence Devices Market Analysis in Europe by Patient Type (2019-2027)
Table 22: Urinary Incontinence Devices Market Analysis in Europe by End User (2019-2027)
Table 23: Urinary Incontinence Devices Market Analysis in Europe by Country (2019-2027)
Table 24: Urinary Incontinence Devices Market Analysis in France (2019-2027)
Table 25: Urinary Incontinence Devices Market Analysis in Germany (2019-2027)
Table 26: Urinary Incontinence Devices Market Analysis in UK (2019-2027)
Table 27: Urinary Incontinence Devices Market Analysis in Italy (2019-2027)
Table 28: Urinary Incontinence Devices Market Analysis in Spain (2019-2027)
Table 29: Urinary Incontinence Devices Market Analysis in Russia (2019-2027)
Table 30: Urinary Incontinence Devices Market Analysis in Rest of Europe (2019-2027)
Table 31: Urinary Incontinence Devices Market Analysis in Asia Pacific (2019-2027)
Table 32: Urinary Incontinence Devices Market Analysis in Asia Pacific by Product (2019-2027)
Table 33: Urinary Incontinence Devices Market Analysis in Asia Pacific by Type (2019-2027)
Table 34: Urinary Incontinence Devices Market Analysis in Asia Pacific by Patient Type (2019-2027)
Table 35: Urinary Incontinence Devices Market Analysis in Asia Pacific by End User (2019-2027)
Table 36: Urinary Incontinence Devices Market Analysis in Asia Pacific by Country (2019-2027)
Table 37: Urinary Incontinence Devices Market Analysis in China (2019-2027)
Table 38: Urinary Incontinence Devices Market Analysis in Japan (2019-2027)
Table 39: Urinary Incontinence Devices Market Analysis in India (2019-2027)
Table 40: Urinary Incontinence Devices Market Analysis in Australia (2019-2027)
Table 41: Urinary Incontinence Devices Market Analysis in South Korea (2019-2027)
Table 42: Urinary Incontinence Devices Market Analysis in Rest of Asia Pacific (2019-2027)
Table 43: Urinary Incontinence Devices Market Analysis in Rest of the World (2019-2027)
Table 44: Urinary Incontinence Devices Market Analysis in Rest of the World by Product (2019-2027)
Table 45: Urinary Incontinence Devices Market Analysis in Rest of the World by Type (2019-2027)
Table 46: Urinary Incontinence Devices Market Analysis in Rest of the World by Patient Type (2019-2027)
Table 47: Urinary Incontinence Devices Market Analysis in Rest of the World by End User (2019-2027)
Table 48: Urinary Incontinence Devices Market Analysis in Rest of the World by Country (2019-2027)
Table 49: Urinary Incontinence Devices Market Analysis in Middle East (2019-2027)
Table 50: Urinary Incontinence Devices Market Analysis in Africa (2019-2027)
Table 51: Urinary Incontinence Devices Market Analysis in South America (2019-2027)List of Figures
Figure 1: Competitive Analysis
Figure 2: COVID-19 Impact Analysis on Urinary Incontinence Devices Market
Figure 3: Urinary Incontinence Devices Market Analysis in Global (2019-2027)
Figure 4: Urinary Incontinence Devices Market Analysis in Global by Product (2019-2027)
Figure 5: Urinary Incontinence Devices Market Analysis in Global by Type (2019-2027)
Figure 6: Urinary Incontinence Devices Market Analysis in Global by Patient Type (2019-2027)
Figure 7: Urinary Incontinence Devices Market Analysis in Global by End User (2019-2027)
Figure 8: Urinary Incontinence Devices Market Analysis in Global by Geography (2019-2027)
Figure 9: Urinary Incontinence Devices Market Analysis in North America (2019-2027)
Figure 10: Urinary Incontinence Devices Market Analysis in North America by Product (2019-2027)
Figure 11: Urinary Incontinence Devices Market Analysis in North America by Type (2019-2027)
Figure 12: Urinary Incontinence Devices Market Analysis in North America by Patient Type (2019-2027)
Figure 13: Urinary Incontinence Devices Market Analysis in North America by End User (2019-2027)
Figure 14: Urinary Incontinence Devices Market Analysis in North America by Country (2019-2027)
Figure 15: Urinary Incontinence Devices Market Analysis in the US (2019-2027)
Figure 16: Urinary Incontinence Devices Market Analysis in Canada (2019-2027)
Figure 17: Urinary Incontinence Devices Market Analysis in Mexico (2019-2027)
Figure 18: Urinary Incontinence Devices Market Analysis in Europe (2019-2027)
Figure 19: Urinary Incontinence Devices Market Analysis in Europe by Product (2019-2027)
Figure 20: Urinary Incontinence Devices Market Analysis in Europe by Type (2019-2027)
Figure 21: Urinary Incontinence Devices Market Analysis in Europe by Patient Type (2019-2027)
Figure 22: Urinary Incontinence Devices Market Analysis in Europe by End User (2019-2027)
Figure 23: Urinary Incontinence Devices Market Analysis in Europe by Country (2019-2027)
Figure 24: Urinary Incontinence Devices Market Analysis in France (2019-2027)
Figure 25: Urinary Incontinence Devices Market Analysis in Germany (2019-2027)
Figure 26: Urinary Incontinence Devices Market Analysis in UK (2019-2027)
Figure 27: Urinary Incontinence Devices Market Analysis in Italy (2019-2027)
Figure 28: Urinary Incontinence Devices Market Analysis in Spain (2019-2027)
Figure 29: Urinary Incontinence Devices Market Analysis in Russia (2019-2027)
Figure 30: Urinary Incontinence Devices Market Analysis in Rest of Europe (2019-2027)
Figure 31: Urinary Incontinence Devices Market Analysis in Asia Pacific (2019-2027)
Figure 32: Urinary Incontinence Devices Market Analysis in Asia Pacific by Product (2019-2027)
Figure 33: Urinary Incontinence Devices Market Analysis in Asia Pacific by Type (2019-2027)
Figure 34: Urinary Incontinence Devices Market Analysis in Asia Pacific by Patient Type (2019-2027)
Figure 35: Urinary Incontinence Devices Market Analysis in Asia Pacific by End User (2019-2027)
Figure 36: Urinary Incontinence Devices Market Analysis in Asia Pacific by Country (2019-2027)
Figure 37: Urinary Incontinence Devices Market Analysis in China (2019-2027)
Figure 38: Urinary Incontinence Devices Market Analysis in Japan (2019-2027)
Figure 39: Urinary Incontinence Devices Market Analysis in India (2019-2027)
Figure 40: Urinary Incontinence Devices Market Analysis in Australia (2019-2027)
Figure 41: Urinary Incontinence Devices Market Analysis in South Korea (2019-2027)
Figure 42: Urinary Incontinence Devices Market Analysis in Rest of Asia Pacific (2019-2027)
Figure 43: Urinary Incontinence Devices Market Analysis in Rest of the World (2019-2027)
Figure 44: Urinary Incontinence Devices Market Analysis in Rest of the World by Product (2019-2027)
Figure 45: Urinary Incontinence Devices Market Analysis in Rest of the World by Type (2019-2027)
Figure 46: Urinary Incontinence Devices Market Analysis in Rest of the World by Patient Type (2019-2027)
Figure 47: Urinary Incontinence Devices Market Analysis in Rest of the World by End User (2019-2027)
Figure 48: Urinary Incontinence Devices Market Analysis in Rest of the World by Country (2019-2027)
Figure 49: Urinary Incontinence Devices Market Analysis in Middle East (2019-2027)
Figure 50: Urinary Incontinence Devices Market Analysis in Africa (2019-2027)
Figure 51: Urinary Incontinence Devices Market Analysis in South America (2019-2027)
Figure 52: Market Drivers
Figure 53: Market Barriers
Figure 54: Market Opportunities
Figure 55: PORTER'S Five Force Analysis
